EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients

J Janukonyté, T Parkner, T Lauritzen, J S Christiansen, T Laursen

Growth Hormone & IGF Research · 2013-12 · 23 (6) · 256-260

DOI: 10.1016/j.ghir.2013.09.002 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Growth Hormone & IGF Research, 2013-12. Verfasst von J Janukonyté und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: JURGITA.JANUKONYTE@KI.AU.DK. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous studies in growth hormone (GH)-deficient (GHD) patients have indicated a possible diurnal variation in the pharmacokinetics (PK) of GH after subcutaneous (sc) GH administration. Thus, higher GH levels were observed during the night with continuous sc infusion, and increased GH bioavailability was reported following daily sc injections in the evening compared to morning. OBJECTIVE: The aim was to study whether diurnal variability in the PK of sc administered exogenous GH can be reproduced under standard conditions for all study participants, e.g. supine rest. DESIGN AND METHODS: Eight male GHD patients (59.8 ± 8 years, body mass index 29.7 ± 4.9 kg/m(2)) received a continuous sc infusion of GH (3mg/24h) for 60 h on two different occasions. Diurnal variation in PK of GH was studied during steady state in the last 24h of the infusion period. RESULTS: Median GH levels were higher at night time (23:00 h-07:00 h) than during the day (10:00 h-18:00 h) for visit 1 [5.1 (4.5-7.2 ng/ml/0.5h) vs. 4.6 (3.7-5.7 ng/ml/0.5h); p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedArea Under CurveCircadian RhythmCross-Over StudiesFemaleFollow-Up StudiesGrowth DisordersHuman Growth HormoneHumansImmunoassayInfusions, SubcutaneousMaleMiddle AgedPrognosisTissue Distribution

Stichwörter der Autor:innen

Continuous subcutaneous infusionDiurnal variationExogenous growth hormoneGrowth hormone deficient

Substanzen

Human Growth Hormone

Autor:innen und Institutionen

  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: JURGITA.JANUKONYTE@KI.AU.DK.

Förderung

  • Novo Nordisk

Zitieren

APA

Janukonyté, J., Parkner, T., Lauritzen, T., Christiansen, J. S., & Laursen, T. (2013). Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients. Growth Hormone & IGF Research, 23(6), 256-260. https://doi.org/10.1016/j.ghir.2013.09.002

Vancouver

Janukonyté J, Parkner T, Lauritzen T, Christiansen JS, Laursen T. Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients. Growth Hormone & IGF Research. 2013;23(6):256-260. doi:10.1016/j.ghir.2013.09.002

BibTeX
@article{Janukonyt2013,
  author = {Janukonyté, J and Parkner, T and Lauritzen, T and Christiansen, J S and Laursen, T},
  title = {Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients},
  journal = {Growth Hormone & IGF Research},
  year = {2013},
  volume = {23},
  number = {6},
  pages = {256--260},
  doi = {10.1016/j.ghir.2013.09.002}
}
Kostenlos starten →